Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia

被引：7
|
作者：
Le, Quy [1 ]
Tang, Thao [1 ]
Leonti, Amanda [1 ]
Castro, Sommer [1 ]
McKay, Cyd Nourigat [1 ]
Perkins, LaKeisha [1 ]
Pardo, Laura [2 ]
Kirkey, Danielle [1 ]
Hylkema, Tiffany [1 ]
Call, Lindsey [1 ]
Manselle, Makia [1 ]
Abrahams, Cristina [3 ]
Bedard, Kristin [3 ]
Molina, Arturo [3 ]
Brodersen, Lisa Eidenshinck [2 ]
Loken, Michael R. [2 ]
Tarlock, Katherine [1 ,5 ]
Meshinchi, Soheil [1 ,4 ,5 ]
Loeb, Keith R. [1 ,6 ,7 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA USA
[2] Hematologics Inc, Seattle, WA USA
[3] Sutro Biopharma, South San Francisco, CA USA
[4] Univ Washington, Dept Pediat, Seattle, WA USA
[5] Childrens Oncol Grp, Monrovia, CA USA
[6] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[7] Fred Hutch Canc Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 09期
关键词：
INVARIANT CHAIN; PROLIFERATION; SURVIVAL;
D O I：
10.1182/bloodadvances.2022008303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1666 / 1670
页数：5
相关论文
共 50 条
  • [41] Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
    van der Lee, Miranda
    van Achtenberg, Tanja
    Brouwers-Vos, Annet
    van der Vleuten, Monique
    Kappers, Wendy
    Verheijden, Gijs
    Huls, Geert A.
    van Wigcheren, Glenn
    Ubink, Ruud
    Sesink, Aloys
    MacInnes, Alyson
    Schuringa, Jan Jacob
    Dokter, Wim
    BLOOD, 2023, 142
  • [42] A Novel Antibody-Drug Conjugate Targeting the CD179a Component of the Surrogate Light Chain for the Treatment of B-Cell Acute Lymphoblastic Leukemia/Lymphoma
    Gordon, Peter
    Williams, Robin
    Ostergaard, Jason
    Muretta, Joseph
    Wilson, Bridget S.
    Lambert, Luke
    Singleton, Timothy P.
    Tasian, Sarah K.
    Winter, Stuart S.
    BLOOD, 2024, 144 : 1407 - 1408
  • [43] The Anti-CD19 Antibody-Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia
    Carol, Hernan
    Szymanska, Barbara
    Evans, Kathryn
    Boehm, Ingrid
    Houghton, Peter J.
    Smith, Malcolm A.
    Lock, Richard B.
    CLINICAL CANCER RESEARCH, 2013, 19 (07) : 1795 - 1805
  • [44] Targeting Sialyl-Thomsen nouveau (STn) antigen with the SGN-STNV antibody-drug conjugate is effective in preclinical studies.
    Schwartz, Alyssa
    Rincon, Hector
    Hansen, Nanna
    Lawrence, Robert
    Anderson, Sarah
    Blesie, Nicole
    Klussman, Kerry
    Epp, Angela
    Gardai, Shyra
    Arthur, William
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma
    Springer, Aaron D.
    Wang, Rengang
    Wang, Jiawei
    Du, Qinyi
    Pi, Willie
    Nguyen, Austin Q.
    Li, Xiaoqing
    Khasanov, Alisher
    Zhu, Tong
    Yan, Zheng
    Hong, Yufeng
    Zhou, Heyue
    Zhang, Yanliang
    Kerwin, Lisa
    Li, Lingna
    Ji, Henry
    Zhang, Hong
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2660 - 2672
  • [46] Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
    Goldberg, Aaron D.
    Atallah, Ehab
    Rizzieri, David
    Walter, Roland B.
    Chung, Ki-Young
    Spira, Alexander
    Stock, Wendy
    Tallman, Martin S.
    Cruz, Hans G.
    Boni, Joseph
    Havenith, Karin E. G.
    Chao, Grace
    Feingold, Jay M.
    Wuerthner, Jens
    Solh, Melhem
    LEUKEMIA RESEARCH, 2020, 95
  • [47] Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy
    Xu, Weili
    Li, Shuai
    Puan, Kia Joo
    Li, Xueting
    Xu, Caili
    Fan, Jiajun
    Dou, Zihan
    Zhang, Jiquan
    Ju, Dianwen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 293
  • [48] LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia
    Anami, Yasuaki
    Deng, Mi
    Gui, Xun
    Yamaguchi, Aiko
    Yamazaki, Chisato M.
    Zhang, Ningyan
    Zhang, Chengcheng
    An, Zhiqiang
    Tsuchikama, Kyoji
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2330 - 2339
  • [49] CD276 (B7-H3) Is an Immunotherapeutic Target in Acute Myeloid Leukemia with Preclinical Efficacy of Vobramitamab Duocarmazine, an Investigational CD276 Antibody-Drug Conjugate
    Kirkey, Danielle C.
    Blankenfeld, Melia
    Hylkema, Tiffany
    Loo, Deryk
    Ward, Ashley
    Robinson, Leila
    Peplinski, Jack H.
    Wallace, Logan K.
    Pardo, Laura
    Menssen, Andrew J.
    Ries, Rhonda E.
    Meshinchi, Soheil
    BLOOD, 2023, 142
  • [50] BYON4413, an in vivo active CD123-targeting antibody-drug conjugate, combines effectively with azacitidine and venetoclax in acute myeloid leukemia cell lines
    van der Lee, Miranda M. C.
    van Achterberg, Tanja
    Hersmus, Kaylee
    Brouwers-Vos, Annet
    van der Vleuten, Monique
    Pruis, Maurien
    Kappers, Wendy
    Verheijden, Gijs
    Huls, Gerwin
    van Wigcheren, Glenn
    Ubink, Ruud
    Sesink, Aloys
    MacInnes, Alyson
    Schuringa, Jan Jacob
    Dokter, Wim
    CANCER RESEARCH, 2024, 84 (06)
12345